Could a common ADHD drug boost brain function in schizophrenia?
NCT ID NCT05414058
First seen Jan 11, 2026 · Last updated Jun 10, 2026 · Updated 15 times
Summary
This study tested whether adding a long-acting stimulant (methylphenidate) to standard antipsychotic medication can improve thinking, memory, and daily functioning in people with schizophrenia or schizoaffective disorder. 35 stable adults took the drug in addition to their usual treatment. The goal was to see if it helps with symptoms like low motivation and trouble concentrating, while monitoring for any worsening of psychosis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA SCHIZOAFFECTIVE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Royal Ottawa Mental Health Centre
Ottawa, Ontario, K1Z 7K4, Canada
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.